Bedel Financial Consulting’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-150
| Closed | -$27K | – | 869 |
|
|
2022
Q1 | $27K | Hold |
150
| – | – | 0.01% | 504 |
|
|
2021
Q4 | $32K | Hold |
150
| – | – | 0.01% | 479 |
|
|
2021
Q3 | $28K | Hold |
150
| – | – | 0.01% | 492 |
|
|
2021
Q2 | $27K | Hold |
150
| – | – | 0.01% | 500 |
|
|
2021
Q1 | $25K | Hold |
150
| – | – | 0.01% | 477 |
|
|
2020
Q4 | $23K | Hold |
150
| – | – | 0.01% | 436 |
|
|
2020
Q3 | $15K | Hold |
150
| – | – | 0.01% | 463 |
|
|
2020
Q2 | $18K | Hold |
150
| – | – | 0.01% | 418 |
|
|
2020
Q1 | $14K | Hold |
150
| – | – | 0.01% | 433 |
|
|
2019
Q4 | $13K | Hold |
150
| – | – | 0.01% | 461 |
|
|
2019
Q3 | $12K | Hold |
150
| – | – | 0.01% | 456 |
|
|
2019
Q2 | $12K | Hold |
150
| – | – | 0.01% | 471 |
|
|
2019
Q1 | $18K | Hold |
150
| – | – | 0.01% | 405 |
|
|
2018
Q4 | $16K | Hold |
150
| – | – | 0.01% | 394 |
|
|
2018
Q3 | $19K | Hold |
150
| – | – | 0.01% | 388 |
|
|
2018
Q2 | $17K | Buy |
+150
| New | +$17K | 0.01% | 404 |
|